latanoprost + minoxidil

**Latanoprost + minoxidil** is a topical pharmaceutical combination under active development and compounding for the treatment of hair loss, particularly androgenetic alopecia. Latanoprost is a prostaglandin F2α analog that promotes hair growth by prolonging the anagen phase of the hair cycle and increasing VEGF synthesis in dermal papilla cells[3][4][5]. Minoxidil is a vasodilator that increases blood flow and nutrient delivery to hair follicles, also upregulating growth factors such as VEGF, prolonging the anagen phase, and stimulating follicular activity[3][4][5]. Together, the combination is believed to provide synergistic effects on follicular stimulation and regrowth, with studies suggesting enhanced efficacy compared to minoxidil or latanoprost alone[1][2][3][4]. Latanoprost is not currently FDA-approved for hair loss, whereas minoxidil is approved in topical form for androgenetic alopecia.

Brand names

ANR-001.1ANR001.1ANR 001.1

Other names

Minoxidil/latanoprost - Aneira Pharmalatanoprost/minoxidilANR-001.1ANR001.1ANR 001.1